The PI3K/AKT/mTOR pathway, which regulates cell survival, metabolism, and protein synthesis, is commonly activated in cancers via mutations or amplification of PI3K subunits, PTEN loss, or growth factor receptor overexpression [98]. The gene discussed is PTEN; the disease is cancer.